Glyscend, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity (NCT06259981) | Glyscend, Inc. | 2024-05-20 |
| A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients (NCT05478525) | Glyscend, Inc. | 2022-08-03 |
Track Glyscend, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.